Shilpa Medicare's Bengaluru facility for the manufacture and testing of Orodispersible films and Transdermal systems has been successfully registered with the Ministry of Health, United Arab Emirates. This registration enables the company to register the products (Orodispersible films and Transdermal systems) in UAE for commercialisation.

The facility is involved in the manufacturing and testing of specialized dosage forms eg. Orodispersible Films and Transdermal systems. The facility is backed up by strong Research and Development of Orodispersible films and transdermal technologies. The GMP facility is equipped with state-of-the-art machinery for the needs of Global commercial requirements. The facility has already been issued GMP by UK MHRA.

The facility also manufactures dietary supplements in orodispersible films and was registered with the US FDA Food Facility registry. The facility is actively exporting dietary supplements to US Market.